Wolverine Trading’s Achillion Pharmaceuticals ACHN Stock Holding History

Wolverine Trading’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-20,600	Closed	-$125K	–	5695
2019 Q4	$125K	Sell	20,600 -4,500	-18%	-$26K	﹤0.01%	4221
2019 Q3	$92K	Buy	+25,100	New	+$96.8K	﹤0.01%	3877
2017 Q4	–	Sell	-25,200	Closed	-$113K	–	5800
2017 Q3	$113K	Buy	25,200 +7,900	+46%	+$35.1K	﹤0.01%	4033
2017 Q2	$78K	Buy	17,300 +1,200	+7%	+$4.82K	﹤0.01%	3971
2017 Q1	$69K	Buy	+16,100	New	+$66.9K	﹤0.01%	3929
2016 Q3	–	Sell	-30,600	Closed	-$240K	–	5339
2016 Q2	$240K	Buy	+30,600	New	+$262K	﹤0.01%	3062

Wolverine Trading's ACHN Position: Q4 2019 in Review

Wolverine Trading sold out of Achillion Pharmaceuticals (ACHN) in Q4 2019, closing a stake of 25,070 shares — an estimated $145K sold.

Wolverine Trading first reported a position in ACHN in Q1 2018 and held it in 3 quarters. The position peaked at $104K in Q2 2018. 132 funds tracked by Wall St. Rank hold ACHN as of Q4 2019.

Wolverine Trading reported no remaining Achillion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Wolverine Trading sold 25,070 Achillion Pharmaceuticals shares in Q4 2019, an estimated $145K.
Wolverine Trading first reported a position in Achillion Pharmaceuticals in Q1 2018 and held it in 3 quarters.
Wolverine Trading's Achillion Pharmaceuticals position peaked at $104K in Q2 2018.
132 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2019.

Based on Wolverine Trading's 13F filing for Q4 2019, filed 12 Feb 2020.